Etamicastat hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameEtamicastat hydrochloride
Drug Alias Name依卡司他etamicastatum依米司他etamicastatBIA-5-453
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine beta-hydroxylase inhibitors
TargetsDopamine beta-hydroxylase
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBial-Portela
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBial - Portela C Sa
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A